<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
  <title>Eurotrack: Singapore</title>
  <subtitle>All entries related to Singapore, newest first.</subtitle>
  <link href="https://eurotrack.ai/en/countries/singapore/"/>
  <link rel="self" href="https://eurotrack.ai/en/countries/singapore/feed.xml"/>
  <id>tag:eurotrack.ai,2026:en:en/countries/singapore</id>
  <updated>2026-09-28T06:00:00Z</updated>
  <author><name>Eurotrack</name></author>
  <entry>
    <title>🤝 Temasek takes 9% stake in Milan-based investor FSI (Italy / Singapore)</title>
    <link href="https://eurotrack.ai/en/developments/de2bb0be-temasek-takes-9-stake-in-milan-based-investor-fsi/"/>
    <id>tag:eurotrack.ai,2026:de2bb0be:en</id>
    <updated>2026-09-28T06:00:00Z</updated>
    <summary>Singapore state investor Temasek has bought 9% of the management company of Milan-based private equity group FSI, which manages about €5bn and invests in mid-sized Italian companies. Temasek is also committing capital to future FSI funds; terms were not disclosed. Temasek has been an investor in FSI funds since 2018 (Reuters via The Star, 28.09.2026; Private Equity Wire, 29.09.2026). — Source: https://www.thestar.com.my/business/business-news/2026/09/28/temasek-buys-9-stake-in-italy039s-fsi-commits-to-future-funds</summary>
  </entry>
  <entry>
    <title>🤝 Sanofi to transfer 20 medicines and three plants to Cheplapharm (Hungary / France / Singapore)</title>
    <link href="https://eurotrack.ai/en/developments/77773a26-sanofi-to-transfer-20-medicines-and-three-plants-to/"/>
    <id>tag:eurotrack.ai,2026:77773a26:en</id>
    <updated>2026-09-14T06:00:00Z</updated>
    <summary>Sanofi is handing 20 older medicines to Greifswald-based specialist Cheplapharm, including the anticoagulant Lovenox/Clexane outside the US, together with three plants: Csanyikvölgy near Miskolc in Hungary with about 400 staff, Jurong in Singapore with about 100 and Ploërmel in France with about 65. In return Sanofi receives a 26.4% stake in Cheplapharm; further financial details are still to come. Staff transfer with their existing contracts and collective agreements, and according to Világgazdaság with a three-year employment guarantee at Miskolc — no job cuts or closures are planned. The products start moving across in the first quarter of 2027, with the plants following after employee consultation and regulatory approvals; everything is due to be completed by the third quarter of 2027 (Bionity, 16 Sep 2026; announced on 14 Sep 2026 according to Világgazdaság, 1 Oct 2026). — Sources: https://www.bionity.com/en/news/1189829/sanofi-is-transferring-20-established-medicines-and-three-manufacturing-sites-to-cheplapharm.html · https://www.vg.hu/vilaggazdasag-magyar-gazdasag/2026/10/sanofi-gyar-eladas-miskolc-dolgozok-munka-nemet-francia</summary>
  </entry>
</feed>
